Xin Y, Xian R, Yang Y, Cong J, Rao Z, Li X
Nat Commun. 2024; 15(1):8719.
PMID: 39379365
PMC: 11461880.
DOI: 10.1038/s41467-024-53037-3.
Wang M, Fan J, Shao Z
Brain Sci. 2024; 14(2).
PMID: 38391729
PMC: 10886843.
DOI: 10.3390/brainsci14020155.
Segev A, Heady L, Crewe M, Madabhushi R
Cell Rep. 2024; 43(2):113809.
PMID: 38377005
PMC: 11064056.
DOI: 10.1016/j.celrep.2024.113809.
Shu J, Jiang J, Wang X, Yang X, Zhao G, Cai T
Cell Death Dis. 2024; 15(1):83.
PMID: 38263255
PMC: 10806188.
DOI: 10.1038/s41419-024-06474-3.
Nettles S, Ikeuchi Y, Lefton K, Abbasi L, Erickson A, Agwu C
Cell Rep. 2023; 42(12):113538.
PMID: 38096051
PMC: 10844882.
DOI: 10.1016/j.celrep.2023.113538.
Maf1 controls retinal neuron number by both RNA Pol III- and Pol II-dependent mechanisms.
Li Y, Xiao D, Chen H, Zheng X, Xiang M
iScience. 2023; 26(12):108544.
PMID: 38089586
PMC: 10711482.
DOI: 10.1016/j.isci.2023.108544.
To Break or Not to Break: The Role of TOP2B in Transcription.
Cowell I, Casement J, Austin C
Int J Mol Sci. 2023; 24(19).
PMID: 37834253
PMC: 10573011.
DOI: 10.3390/ijms241914806.
Telling Your Right Hand from Your Left: The Effects of DNA Supercoil Handedness on the Actions of Type II Topoisomerases.
Jian J, Osheroff N
Int J Mol Sci. 2023; 24(13).
PMID: 37446377
PMC: 10342825.
DOI: 10.3390/ijms241311199.
Basis for the discrimination of supercoil handedness during DNA cleavage by human and bacterial type II topoisomerases.
Jian J, McCarty K, Byl J, Guengerich F, Neuman K, Osheroff N
Nucleic Acids Res. 2023; 51(8):3888-3902.
PMID: 36999602
PMC: 10164583.
DOI: 10.1093/nar/gkad190.
Topoisomerases in Immune Cell Development and Function.
Muralidhara P, Kumar A, Chaurasia M, Bansal K
J Immunol. 2023; 210(2):126-133.
PMID: 36596219
PMC: 7614072.
DOI: 10.4049/jimmunol.2200650.
Disease-associated H58Y mutation affects the nuclear dynamics of human DNA topoisomerase IIβ.
Morotomi-Yano K, Hiromoto Y, Higaki T, Yano K
Sci Rep. 2022; 12(1):20627.
PMID: 36450898
PMC: 9712534.
DOI: 10.1038/s41598-022-24883-2.
Untangling the roles of TOP2A and TOP2B in transcription and cancer.
Uuskula-Reimand L, Wilson M
Sci Adv. 2022; 8(44):eadd4920.
PMID: 36322662
PMC: 9629710.
DOI: 10.1126/sciadv.add4920.
Recognition of DNA Supercoil Handedness during Catenation Catalyzed by Type II Topoisomerases.
Dalvie E, Stacy J, Neuman K, Osheroff N
Biochemistry. 2022; 61(19):2148-2158.
PMID: 36122251
PMC: 9548324.
DOI: 10.1021/acs.biochem.2c00370.
Topoisomerase 2β and DNA topology during B cell development.
Papapietro O, Nejentsev S
Front Immunol. 2022; 13:982870.
PMID: 36045673
PMC: 9423374.
DOI: 10.3389/fimmu.2022.982870.
Investigating the Anticancer Potential of Salvicine as a Modulator of Topoisomerase II and ROS Signaling Cascade.
Dey D, Hasan M, Biswas P, Papadakos S, Rayan R, Tasnim S
Front Oncol. 2022; 12:899009.
PMID: 35719997
PMC: 9198638.
DOI: 10.3389/fonc.2022.899009.
A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193.
Ling E, Basle A, Cowell I, van den Berg B, Blower T, Austin C
Structure. 2022; 30(8):1129-1145.e3.
PMID: 35660158
PMC: 9592559.
DOI: 10.1016/j.str.2022.05.009.
Human topoisomerases and their roles in genome stability and organization.
Pommier Y, Nussenzweig A, Takeda S, Austin C
Nat Rev Mol Cell Biol. 2022; 23(6):407-427.
PMID: 35228717
PMC: 8883456.
DOI: 10.1038/s41580-022-00452-3.
Evolutionary History of TOPIIA Topoisomerases in Animals.
Moreira F, Arenas M, Videira A, Pereira F
J Mol Evol. 2022; 90(2):149-165.
PMID: 35165762
DOI: 10.1007/s00239-022-10048-2.
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.
Pan M, Wright W, Chapple R, Zubair A, Sandhu M, Batchelder J
Nat Commun. 2021; 12(1):6468.
PMID: 34753908
PMC: 8578635.
DOI: 10.1038/s41467-021-26640-x.
Nucleolar translocation of human DNA topoisomerase II by ATP depletion and its disruption by the RNA polymerase I inhibitor BMH-21.
Morotomi-Yano K, Yano K
Sci Rep. 2021; 11(1):21533.
PMID: 34728715
PMC: 8563764.
DOI: 10.1038/s41598-021-00958-4.